Top Markets
#1 Akedo Akedo +64.92%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.99%
#4 Velvet Velvet +39.58%
#5 Black Phoenix Black Phoenix +34.15%
#6 Cross Cross +32.99%
#7 Cap Cap +29.09%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.02%
#9 DoubleZero DoubleZero +13.10%
#10 Humanity Humanity +11.79%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
OncoCyte Corporation OncoCyte Corporation

OncoCyte Corporation

OCX
Rank in Stocks #38932
OncoCyte Corporation is a molecular diagnostics firm that conceptualizes,... OncoCyte Corporation is a molecular diagnostics firm that conceptualizes, refines, and brings to market its exclusive laboratory-developed tests aimed at identifying cancer in patients, serving both the United States and global markets. The company's portfolio features DetermaRx, a specialized molecular test for detecting early-stage adenocarcinoma in the lung, alongside DetermaIO, a unique proprietary assay that assesses gene expression. In addition to its diagnostic offerings, OncoCyte provides a suite of services including biomarker discovery, the design and development of new assays, and essential support for clinical trials. It also delivers various biomarker testing solutions specifically tailored for pharmaceutical companies. OncoCyte has established a collaborative agreement with Life Technologies Corporation. This partnership is geared towards the co-development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, which are designed for use with the Ion Torrent Genexus integrated sequencer and purification system. The corporation was founded in 2009 and its primary base of operations is situated in Irvine, California.
Share Price
$2.84
Last synced: 2025-07-14
Market Cap
$729.71K
Change (1 day)
-0.70%
Change (1 year)
0.00%
Country
US
Trade OncoCyte Corporation (OCX)

Category

Healthcare
Stock price history for OncoCyte Corporation (OCX)
Highest end of day price: $2.94 on 2025-07-01

Lowest end of day price: $143.30 on 2015-12-01
Stock price history of OncoCyte Corporation from 2015 to 2026
Annual Stock Price Performance
Year Performance
2025 27.15%
2024 -24.10%
2023 -60.24%
2022 -83.06%
2021 -0.14%
2020 13.17%
2019 31.74%
2018 -71.95%
2017 -19.84%
2016 -5.81%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $507.84 30.12%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $845.14 29.54%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $728.57 6.67%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $252.77 11.67%
BE